ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,437,000 | +35.0% | 60,000 | +6.1% | 0.00% | +100.0% |
| Q1 2023 | $1,064,366 | +127.9% | 56,555 | +182.8% | 0.00% | – |
| Q4 2021 | $467,000 | -89.8% | 20,000 | -82.0% | 0.00% | -100.0% |
| Q3 2020 | $4,588,000 | +28575.0% | 111,217 | +10846.6% | 0.00% | – |
| Q4 2018 | $16,000 | -98.3% | 1,016 | -97.8% | 0.00% | -100.0% |
| Q3 2018 | $964,000 | +35.6% | 46,493 | -0.1% | 0.00% | 0.0% |
| Q2 2018 | $711,000 | -56.7% | 46,542 | -36.3% | 0.00% | -50.0% |
| Q1 2018 | $1,643,000 | +9027.8% | 73,100 | +11942.8% | 0.00% | – |
| Q4 2017 | $18,000 | -99.4% | 607 | -99.3% | 0.00% | -100.0% |
| Q3 2017 | $3,070,000 | +23.4% | 81,482 | -8.6% | 0.01% | +25.0% |
| Q2 2017 | $2,488,000 | -20.9% | 89,196 | -20.7% | 0.00% | -42.9% |
| Q1 2016 | $3,146,000 | – | 112,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |